Approval · Notice of Compliance 21728 · 2019
VOLTAREN RAPIDE: Notice of Compliance 21728
Issued January 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21728
- Date
- January 11, 2019
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition to an alternate drug substance manufacturing and testing site; addition of drug substance testing sites; changes to the drug substance manufacturing process; change in drug substance batch size; chage to starting material test method; and addition of raw material specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLTAREN RAPIDE | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC POTASSIUM 50 MG per TAB